Stonepine Capital Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-482,258
| Closed | -$680K | – | 24 |
|
|
2023
Q4 | $680K | Sell |
482,258
-4,144,366
| -90% | -$5.84M | 0.29% | 16 |
|
|
2023
Q3 | $7.31M | Sell |
4,626,624
-600
| -0% | -$948 | 2.43% | 10 |
|
|
2023
Q2 | $9.99M | Sell |
4,627,224
-198,498
| -4% | -$429K | 3.61% | 9 |
|
|
2023
Q1 | $10.1M | Buy |
+4,825,722
| New | +$10.1M | 3.4% | 9 |
|
|
2022
Q4 | – | Sell |
-600,980
| Closed | -$1.8M | – | 24 |
|
|
2022
Q3 | $1.8M | Sell |
600,980
-600
| -0.1% | -$1.8K | 0.81% | 16 |
|
|
2022
Q2 | $1.7M | Hold |
601,580
| – | – | 0.79% | 20 |
|
|
2022
Q1 | $3.22M | Buy |
601,580
+76,049
| +14% | +$407K | 1.33% | 16 |
|
|
2021
Q4 | $3.93M | Buy |
525,531
+114,996
| +28% | +$859K | 1.8% | 13 |
|
|
2021
Q3 | $3.73M | Buy |
+410,535
| New | +$3.73M | 1.7% | 14 |
|